192
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension

, , &
Pages 1073-1079 | Received 18 Jul 2019, Accepted 03 Dec 2019, Published online: 16 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stylianos Kandarakis, Alexandros P. Papadopoulos, Georgios Roussopoulos, Eustathios Georgopoulos, Youngsik Chung, Leonidas Doumazos, Areum Baek, Nefeli Ioanna Paizi, Hyunik Shin & Pantelis A. Papadopoulos. (2023) COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Expert Opinion on Drug Safety 0:0, pages 1-12.
Read now

Articles from other publishers (1)

Subramanyam PolopalliAchintya SahaPakter NiriMohit KumarParikshit DasDev Vrat KambojPronobesh Chattopadhyay. (2023) ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review. Journal of Ocular Pharmacology and Therapeutics 39:9, pages 585-599.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.